Biotech Veteran Henney Gets Key Role in Startup CG Therapeutics

Published: Sep 24, 2007

Christopher Henney -- who co-founded three of Seattle's biggest biotech companies, Immunex, Icos Corp. and Dendreon -- is now tossing his weight behind a new startup company called CG Therapeutics. Henney was named chairman of the board, with the role of helping the startup with venture funding and corporate partnerships, the company announced Thursday.

Back to news